| Pulse duration | Pulses are in the nanosecond range (10⁻⁹ seconds). | Pulses are shorter, in the picosecond range (10⁻¹² seconds). | Pulse duration alone does not establish which option is safer or more effective for melasma. |
| How it may affect pigment | Depending on the device and settings, pigment-targeting treatment may use selective photothermal and photoacoustic effects. | The shorter pulse can produce a stronger photoacoustic component; effects depend on wavelength, spot size, and settings. | Ask how the proposed wavelength and settings are suited to the pigment pattern and your skin tone. |
| Evidence for melasma | Some low-fluence Q-switched approaches have been studied, but results vary and improvement may not last. | Studies report potential benefit in some patients, but evidence does not show that picosecond treatment is universally superior. | Request realistic expectations, the evidence for the exact approach, and a plan for maintenance and recurrence. |
| Potential benefits | May reduce visible pigmentation in carefully selected cases when used conservatively as part of a broader treatment plan. | May be considered for selected cases; a shorter pulse does not guarantee fewer sessions, better results, or less downtime. | Clarify the expected degree of improvement and whether non-laser treatment is more appropriate first. |
| Risks and limitations | Possible risks include post-inflammatory hyperpigmentation, uneven lightening, irritation, and recurrence; repeated treatment can increase concern about mottled hypopigmentation. | Can also cause post-inflammatory hyperpigmentation, irritation, uneven lightening, or recurrence. “Picosecond” does not mean risk-free. | Discuss your history of pigment changes, recent tanning, medications, and how complications would be managed. |
| Skin tone considerations | Darker or easily pigmented skin may be more prone to post-inflammatory color changes; risk depends on treatment parameters and individual factors. | The same caution applies; pulse duration alone does not remove the risk associated with skin tone or inflammation. | Ask whether a test spot is appropriate and how your response will be assessed before broader treatment. |
| Usual place in care | Typically an adjunctive option for selected patients, rather than a substitute for ongoing melasma care. | Also an adjunctive option; suitability depends on diagnosis, prior treatment, and risk tolerance. | Ask whether to begin with broad-spectrum sun protection and dermatologist-guided topical treatment. |
| Prevention and follow-up | Melasma commonly returns, especially with ultraviolet and visible-light exposure. Sun protection and a maintenance plan remain important whether or not a laser is used. | Discuss daily broad-spectrum sunscreen, visible-light protection where appropriate, follow-up timing, and when to stop or modify treatment. |